INDIA’S Tata owned Jaguar Land Rover (JLR) is on its way to invest a huge sum in advanced manufacturing in the UK.
Quoting the sources close to the auto giant and the UK government, BBC reported that new investment in Britain was imminent.
JLR is expected to make a formal announcement on its new investment later this month, the broadcaster added.
The British government hopes that the new investment will confirm the UK still has a major role to play in JLR’s move to electric vehicles despite some existing model production being moved to Slovakia.
Earlier this year, JLR unveiled its strategy to axe 4,500 jobs in the next 24 months amid declining demand for diesel engines which presently power 90 per cent of its range.
The company has also witnessed a fall in demand for cars in China, its most profitable market.
The auto maker has also plans to pump hundreds of millions pounds into the UK plants as part of its strategy to electrify its range of cars.
JLR chief executive Ralf Speth has recently stated that by 2020 all of its vehicle models will be available with some form of electric power.
The new investment will move into building a new battery assembly plant at Hams Hall, near Birmingham, and setting up its existing engine plant in Wolverhampton to make electric drive systems.
As part of its future strategy, JLR wants the Hams Hall plant to be operational and to be producing its own electric vehicles by 2020.
Further investment is expected to come with the preparation for a revamped Range Rover at Solihull, after JLR shifted its Discovery model production from the plant to its new site in Slovakia in 2018.
Ian Henry of AutoAnalysis said: “Putting a figure on how much JLR is going to spend is almost impossible without knowing the detail. However, as a comparison Toyota just spent £240m into retooling its UK plant so it could make the Corolla - a smaller and less complex car. I’d expect investment for an all-new Range Rover, for example, to be a lot higher.”
The UK auto industry is expected to get a big push from the upcoming latest investment when the British auto industry has been in a series of bad news in recent days.
The auto maker has also taken steps to strengthen its relations with its dealer network in China as part of its efforts to expand and strengthen its auto business further.
According to the UK’s Society of Motor Manufacturers and Traders (SMMT) the sales of UK manufactured cars declined 72 per cent in the last month when compared to the same period last year but sources at JLR said there were "green shoots of recovery" in the Chinese car market.
Veterinary practices ordered to publish price lists and disclose corporate ownership under new CMA proposals.
Pet healthcare costs have risen at nearly twice the rate of inflation, investigation finds.
CVS Group shares surge 18 per cent as market welcomes lack of direct price controls on medicines.
Watchdog pushes for price transparency
Britain’s competition watchdog has provisionally ordered veterinary practices to publish price lists and disclose corporate ownership, aiming to give pet owners greater transparency in a sector where costs have risen at nearly twice the rate of inflation.
The Competition and Markets Authority (CMA) said on Wednesday (15) that pet owners are often unaware of prices or not given estimates for treatments that can run into thousands of pounds.
Under the proposed measures, vet businesses must publish prices for common procedures and make clear which practices are independent and which belong to large corporate chains. The watchdog also plans to cap prescription fees and ban bonuses linked to specific treatments.
“We believe that the measures we are proposing would be beneficial to the sector as a whole, including vets and vet nurses,” the CMA stated in its provisional decision report. “Providing better information for pet owners will increase their confidence in vet businesses and the profession.”
Industry reactions
The announcement triggered immediate market reactions. Bloomberg reported Shares of CVS Group, a British veterinary services provider, rose as much as 18 per cent in early London trading before paring gains, whilst Pets at Home traded up to 4.9 per cent higher. Both companies had underperformed since the CMA launched its investigation.
“While the tone of the CMA’s report is sharp, we see few surprises versus our expectations,” said Jefferies analyst Andrew Wade to Bloomberg. “The lack of pricing controls on services notably medicines must be viewed as a positive.”
The veterinary profession offered cautious support for the reforms. Dr Rob Williams, president of the British Veterinary Association, said: “At first glance, there’s lots of positives in the CMA’s provisional decision that both vets and pet owners will welcome, including greater transparency of pricing and practice ownership."
However, animal welfare charities warned of the consequences when pet owners delay treatment due to cost concerns. Caroline Allen, the RSPCA’s Chief Veterinary Officer, told BBC “Our frontline officers sadly see first-hand the consequences when people delay or avoid seeking professional help, or even attempt to treat conditions themselves."
The proposed remedies package also includes requirements for vet businesses to improve complaint processes and conduct regular customer satisfaction surveys comparing large groups with independent practices. Additionally, practices would find it easier to terminate out-of-hours contracts with third-party providers if better alternatives exist.
The CMA emphasised that vet businesses failing to comply, or those pressuring veterinarians to act in certain ways or sell specific treatments, could be in breach of the Order.
By clicking the 'Subscribe’, you agree to receive our newsletter, marketing communications and industry
partners/sponsors sharing promotional product information via email and print communication from Garavi Gujarat
Publications Ltd and subsidiaries. You have the right to withdraw your consent at any time by clicking the
unsubscribe link in our emails. We will use your email address to personalize our communications and send you
relevant offers. Your data will be stored up to 30 days after unsubscribing.
Contact us at data@amg.biz to see how we manage and store your data.